The Bio-Therapeutic Impact Award accelerates the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules.  The award, intended for investigators who are initiating clinical trials, totals the maximum of $1.8 million awarded over three years.

Download the Bio-Therapeutics Impact Grant Application Guidelines